Intellia Therapeutics, Inc. · NASDAQ:NTLA
State Street Corp reported a 5.50% stake in Intellia Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 9, 2026
State Street Corp reported a 5.50% stake in Intellia Therapeutics, Inc., 6,418,836 shares, as a passive investor on Dec 31, 2025. Filed Feb 9, 2026 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 6,418,836
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.50% | 6,418,836 |
Source
Related
- Intellia Therapeutics, Inc.
- State Street Corp
- Intellia Therapeutics, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G · State Street Corp · May 13, 2025
- Form 4 · Dube Michael P · Oct 6, 2026
- Form 4 · Leonard John M · Aug 24, 2026
- Form 4 · Dulac Edward J III · Jul 24, 2026
- Form 4 · Dulac Edward J III · Jul 6, 2026
- Form 4 · Dube Michael P · Jul 6, 2026